The global pulmonary artery catheter market is experiencing steady expansion, with valuations expected to grow from USD 1.23 billion in 2025 to USD 1.97 billion by 2035, representing a compound annual growth rate of 4.87%. This sustained expansion reflects broader trends in critical care infrastructure and clinical demand for advanced hemodynamic monitoring technologies across healthcare systems worldwide.
Several factors are contributing to this market trajectory. The rising prevalence of cardiovascular disease, coupled with an increase in critical care procedures globally, continues to drive adoption of pulmonary artery catheters in intensive care units. Healthcare facilities are simultaneously expanding their ICU capacities to meet growing patient volumes, creating additional demand for diagnostic and monitoring equipment. The clinical emphasis on precise hemodynamic assessment in critically ill patients further reinforces the market's growth outlook.
Regionally, the United States represents a significant market segment, with projections indicating growth from USD 0.38 billion in 2025 to USD 0.58 billion by 2035. This performance reflects the mature nature of the U.S. healthcare infrastructure and the established role of hemodynamic monitoring in critical care protocols across American medical institutions.